SCHEMBL10100412

SCHEMBL10100412

CCCCOC[C@H]1O[C@@H](c2ccc3c(C)ncnn23)[C@](C)(O)[C@@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9912348 0.79 DOT1L (0.30) —
SCHEMBL11924463 0.79 DOT1L (0.30) —
SCHEMBL14140990 0.79 — —
SCHEMBL15682803 0.77 POLRMT (0.39) —
SCHEMBL13532237 0.77 — —
SCHEMBL15682807 0.75 POLRMT (0.30) —
SCHEMBL10143786 0.72 — —
SCHEMBL10142421 0.72 — —
SCHEMBL9912333 0.71 — —
SCHEMBL13667813 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114980-B1 ANTIVIRAL NUCLEOSIDE ANALOGS BIOCRYST PHARM INC (US) 2012-06-27 — — EP disclosed
Send feedback